Navigation Links
Idenix Pharmaceuticals to Present at an Upcoming Investor Conference
Date:10/26/2010

CAMBRIDGE, Mass., Oct. 26 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that Idenix management will present a corporate overview at the Oppenheimer & Co. 21st Annual Healthcare Conference on Wednesday, November 3, 2010 at 3:20 p.m. ET at the Waldorf Astoria, New York City.

The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at www.idenix.com. Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conference.

About Idenix Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of patients with chronic hepatitis C infection. For further information about Idenix, please refer to http://www.idenix.com. Idenix Pharmaceuticals Contact: Jonae Barnes (617) 224-4485 (investors) Kelly Barry (617) 995-9033 (media)
'/>"/>

SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
2. Idenix Retains Worldwide Rights to Develop and Commercialize IDX184 for the Treatment of HCV
3. Idenix Announces Data Presentations at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Idenix Pharmaceuticals Prices Underwritten Offering of Common Stock
6. Idenix Pharmaceuticals Reports Second Quarter and Six Month 2009 Financial Results
7. Idenix to Host Conference Call Discussing Second Quarter 2009 Financial Results
8. Idenix Pharmaceuticals to Present at The Deutsche Bank 2009 Health Care Conference
9. Idenix Pharmaceuticals Reports First Quarter Financial Results
10. Idenix Pharmaceuticals Reports Data From Three Hepatitis C Development Programs at the 44th Annual Meeting of the European Association for the Study of the Liver
11. Idenix Pharmaceuticals to Present at the Canaccord Adams Hepatitis C Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)...  Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the ... and commercializing products to treat rare diseases where ... the long-term follow-up data from its Phase 2 ... Defense Regulator (IDR), in the treatment of oral ... undergoing chemoradiation therapy (CRT).  The additional 12-month safety ...
(Date:12/8/2016)...  Partnering to fuel Philadelphia,s ... Southeastern Pennsylvania (" Ben Franklin ... Independence Blue Cross; and Safeguard Scientifics ("Safeguard") (NYSE: ... $6 million funding initiative over a four year period ... to a burgeoning economic vitality in digital health, ...
(Date:12/7/2016)... , Dec. 7, 2016 Neogen Corporation ... named Dr. Dan Kephart as its chief ... Kephart will assume his responsibilities at Neogen effective Jan. ... development director for the agribusiness unit of Thermo Fisher ... development at Life Technologies. His extensive industry experience also ...
(Date:12/7/2016)... PUNE, India , December 8, 2016 The report "Acrylic ... (Building & Construction, Packaging, Automotive, Consumer Goods) - Global Forecast to 2026", published ... is projected to reach USD 1,173.6 Million by 2026, registering an of CAGR ... ... MarketsandMarkets Logo ...
Breaking Biology Technology:
(Date:11/30/2016)... WARSAW, Poland , Nov. 30, 2016 Not many of us ... most crucial aspects of recovery so we need to do it well. Inadequate sleep ... heart problems, high blood pressure, stroke, diabetes, and even cancer. Maybe now ... a Christmas present that could help them to manage their sleep quality? ... ...
(Date:11/28/2016)... "The biometric system market ... The biometric system market is in the growth stage ... future. The biometric system market is expected to be ... CAGR of 16.79% between 2016 and 2022. Government initiative ... in smartphones, rising use of biometric technology in financial ...
(Date:11/19/2016)... Nov. 18, 2016 Securus Technologies, a leading ... public safety, investigation, corrections and monitoring, announced today that ... ICSolutions, to have an independent technology judge determine who ... modern high tech/sophisticated telephone calling platform, and the best ... they do most of what we do – which ...
Breaking Biology News(10 mins):